KRAS and colorectal cancer: In this study, 25% of the patients had a right-sided colorectal cancer and 57% showed KRAS mutations, whereas the proportion of patients with a right-sided colorectal cancer in the study of Liao et al. [13] was significantly higher (45%), and the number of KRAS mutations was significantly lower (35%) [13].